Case number: 1:22-bk-11294 - Clovis Oncology Ireland Limited - Delaware Bankruptcy Court

Case Information
  • Case title

    Clovis Oncology Ireland Limited

  • Court

    Delaware (debke)

  • Chapter

    11

  • Judge

    J Kate Stickles

  • Filed

    12/11/2022

  • Last Filing

    01/26/2023

  • Asset

    Yes

  • Vol

    v

Docket Header
JNTADMN, CLMSAGNT



U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 22-11294-JKS

Assigned to: Bankruptcy Judge J Kate Stickles
Chapter 11
Voluntary
Asset


Date filed:  12/11/2022

Debtor

Clovis Oncology Ireland Limited

1st Floor, Building Two
The Green Dublin Airport Central
Dublin Airport
Swords
OUTSIDE U. S.
Dublin, Ireland
Tax ID / EIN: 00-0000000

represented by
Robert J. Dehney

Morris, Nichols, Arsht & Tunnell
1201 N. Market Street
P O. Box 1347
Wilmington, DE 19899-1347
(302) 658-9200
Fax : (302) 658-3989
Email: rdehney@mnat.com

U.S. Trustee

U.S. Trustee

Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491

 
 
Claims Agent

Kroll Restructuring Administration LLC

(f/k/a Prime Clerk LLC)
55 East 52nd Street
17th Floor
New York, NY 10055
212-257-5450
 
 

Latest Dockets

Date Filed#Docket Text
12/15/20229An order has been entered in this case in accordance with Bankruptcy Rule 1015(b) directing the procedural consolidation and joint administration of the chapter 11 cases of Clovis Oncology, Inc., Clovis Oncology UK Limited, and Clovis Oncology Ireland Limited. The docket in the chapter 11 case of Clovis Oncology, Inc., Case No. 22-11292 (JKS), should be consulted for all matters affecting these cases. (related document(s)8) (SJM) (Entered: 12/15/2022)
12/14/20228Order Directing Joint Administration of Cases " An order has been entered in this case in accordance with Bankruptcy Rule 1015(b) directing the procedural consolidation and joint administration of the chapter 11 cases of Clovis Oncology, Inc., Clovis Oncology UK Limited, and Clovis Oncology Ireland Limited. The docket in the chapter 11 case of Clovis Oncology, Inc., Case No. 22-11292 (JKS), should be consulted for all matters affecting these cases." Signed on 12/14/2022 (AJL) (Entered: 12/14/2022)
12/12/20227Order Approving Motion for Admission pro hac vice (Related Doc # 5) (related document(s)5) Order Signed on 12/12/2022. (AJL) (Entered: 12/12/2022)
12/12/20226Certificate of Service Certificate of Service to Entry of Appearance and Request for Notices of 3B Pharmaceuticals GmbH Pursuant to Fed. R. Bankr. P. 2002 and 9010 and Del. Bankr. L.R. 2002-1(d) Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022)
12/12/2022Attorney Paul D. Moak and Mark W. Eckard for 3B Pharmaceuticals GmbH added to case Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022)
12/12/20225Motion to Appear pro hac vice of Paul D. Moak. Receipt Number 3908008, Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022)
12/12/20224Notice of Appearance. Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022)
12/12/2022Judge J Kate Stickles added to case (SJS) (Entered: 12/12/2022)
12/12/20223Motion for Joint Administration // Debtors' Motion for Order Authorizing Joint Administration of the Debtors' Chapter 11 Cases Filed By Clovis Oncology Ireland Limited (Attachments: # 1 Exhibit A: Proposed Order)(Dehney, Robert) (Entered: 12/12/2022)
12/11/20222Receipt of filing fee for Voluntary Petition (Chapter 11)( 22-11294) [misc,volp11a] (1738.00). Receipt Number A10932501, amount $1738.00. (U.S. Treasury) (Entered: 12/11/2022)